Blume Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Blume Capital Management's OGN Position: Q1 2026 in Review
Blume Capital Management opened a new position in Organon & Co (OGN) in Q1 2026: 5 shares worth $30. The stake represents ﹤0.01% of the portfolio and ranks #336 among its holdings. This is a return to the name: Blume Capital Management previously reported a position in OGN as recently as Q2 2022.
Blume Capital Management first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. The position peaked at $6K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Blume Capital Management held 5 shares of Organon & Co worth $30 as of Q1 2026.
- Organon & Co was a new Blume Capital Management position in Q1 2026.
- Organon & Co made up ﹤0.01% of Blume Capital Management's portfolio in Q1 2026, its #336 holding.
- Blume Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
- Blume Capital Management's Organon & Co position peaked at $6K in Q2 2021.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Blume Capital Management's 13F filing for Q1 2026, filed 1 May 2026.